期刊文献+

Mitochondrial metabolomic profiling for elucidating the alleviating potential of Polygonatum kingianum against high-fat diet-induced nonalcoholic fatty liver disease 被引量:6

Mitochondrial metabolomic profiling for elucidating the alleviating potential of Polygonatum kingianum against high-fat diet-induced nonalcoholic fatty liver disease
下载PDF
导出
摘要 BACKGROUND Developing mitochondrial regulators/nutrients from natural products to remedy mitochondrial dysfunction represent attractive strategies for therapy of nonalcoholic fatty liver disease(NAFLD).Polygonatum kingianum(PK)has been traditionally used in China as a medicinal and nutritional ingredient for centuries and can alleviate high-fat diet(HFD)-induced NAFLD by promoting mitochondrial functions.To date,the underlying molecular mechanism of PK for treating mitochondrial dysfunctions and thus alleviating NAFLD remains unclear.AIM To identify the molecular mechanism behind the mitochondrial regulatory action of PK against HFD-induced NAFLD in rats.METHODS NAFLD model was induced in rats with HFD.The rats were intragastrically administered PK(4 g/kg per day)for 14 wk.Metabolites in hepatic mitochondrial samples were profiled through ultra-high performance liquid chromatography/mass spectrometry followed by multivariate statistical analysis to find the potential biomarkers and metabolic pathways.RESULTS PK significantly restored the metabolites’levels in the mitochondrial samples.Ten potential biomarkers were identified in the analyzed samples.These biomarkers are involved in riboflavin metabolism.CONCLUSION PK can alleviate HFD-induced NAFLD by regulating the riboflavin metabolism and further improving the mitochondrial functions.Thus,PK is a promising mitochondrial regulator/nutrient for alleviating NAFLD-associated diseases. BACKGROUND Developing mitochondrial regulators/nutrients from natural products to remedy mitochondrial dysfunction represent attractive strategies for therapy of nonalcoholic fatty liver disease(NAFLD). Polygonatum kingianum(PK) has been traditionally used in China as a medicinal and nutritional ingredient for centuries and can alleviate high-fat diet(HFD)-induced NAFLD by promoting mitochondrial functions. To date, the underlying molecular mechanism of PK for treating mitochondrial dysfunctions and thus alleviating NAFLD remains unclear.AIM To identify the molecular mechanism behind the mitochondrial regulatory action of PK against HFD-induced NAFLD in rats.METHODS NAFLD model was induced in rats with HFD. The rats were intragastrically administered PK(4 g/kg per day) for 14 wk. Metabolites in hepatic mitochondrial samples were profiled through ultra-high performance liquid chromatography/mass spectrometry followed by multivariate statistical analysis to find the potential biomarkers and metabolic pathways.RESULTS PK significantly restored the metabolites’ levels in the mitochondrial samples.Ten potential biomarkers were identified in the analyzed samples. These biomarkers are involved in riboflavin metabolism.CONCLUSION PK can alleviate HFD-induced NAFLD by regulating the riboflavin metabolism and further improving the mitochondrial functions. Thus, PK is a promising mitochondrial regulator/nutrient for alleviating NAFLD-associated diseases.
出处 《World Journal of Gastroenterology》 SCIE CAS 2019年第43期6404-6415,共12页 世界胃肠病学杂志(英文版)
基金 the National Natural Science Foundation of China,No.81660596 the National Natural Science Foundation of China,No.81760733 the Science and Technology Project of Yunnan China,No.2017FF117-013 the Science and Technology Project of Yunnan China,No.2016FD050 the Application and Basis Research Project of Yunnan China,No.201801CH00227
关键词 Metabolomics MITOCHONDRIA Multivariate statistical analysis Non-alcoholic FATTY liver POLYGONATUM kingianum Ultra-high performance liquid chromatography/mass SPECTROMETRY Metabolomics Mitochondria Multivariate statistical analysis Non-alcoholic fatty liver Polygonatum kingianum Ultra-high performance liquid chromatography/mass spectrometry
  • 相关文献

参考文献1

二级参考文献17

  • 1雷怀成,宋道江,易建华,朱方成,顾玉林.大鼠乌头碱中毒心肌细胞凋亡的研究[J].中国工业医学杂志,2004,17(6):373-374. 被引量:32
  • 2Tong P, Wu C, Wang X, Hu H, Jin H, Li C, Zhu Y, Shan L, Xiao L. J. Ethnopharmacol., 2013, 146(2):562-571.
  • 3Peng W W, Li W, Li J S, Cui X B, Zhang Y X, Yang G M, Wen H M, Cai B C. J. Ethnopharmacol., 2013, 148(2):579-586.
  • 4Xiao K, Wang L, Liu Y, Peng C, Yan G, Zhang J, Zhuo Y, Li H. Birth Defects Res. B:Dev. Reprod. Toxicol., 2007, 80(3):208-212.
  • 5Caserta D, Graziano A, Lo Monte G, Bordi G, Moscarini M. Eur. Rev. Med. Pharmacol. Sci., 2013, 17(16):2198-2206.
  • 6Myllynen P, Pasanen M, Pelkonen O. Placenta, 2005, 26(5):361-371.
  • 7Prouillac C, Lecoeur S. Drug Metab. Dispos., 2010, 38(10):1623-1635.
  • 8Zhang Z H, Zhao Y Y, Cheng X L, Dai Z, Zhou C, Bai X, Lin R C. J. Ethnopharmacol., 2013, 149(1):303-310.
  • 9Jones H N, Powell T L, Jansson T. Placenta, 2007, 28(8-9):763-774.
  • 10Kalhan S C. Am. J. Clin. Nutr., 2000, 71(5):S1249-S1255.

共引文献14

同被引文献102

引证文献6

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部